Is H35.352 a billable ICD-10-CM code?

Yes. H35.352 is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does H35.352 sit in the tabular list?

Diseases of the eye and adnexa (H00-H59), in the block Disorders of choroid and retina (H30-H36).

What cannot be coded together with H35.352?

H35.352 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above H35.352 (H35.35) and apply to it just the same.

H35.352

H35.352 — Cystoid macular degeneration, left eye

Billable / specific codeICD-10-CMleft

H35.352 is a billable, specific ICD-10-CM code for cystoid macular degeneration, left eye. It is valid for submission on a claim.

Excludes1 inherited from the categories above H35.352

These are not written on H35.352, but they bind it: a note on a category applies to every code beneath it. Billing H35.352 with anything listed here is a denial.

Written on H35.35 — Cystoid macular degeneration

cystoid macular edema following cataract surgery (H59.03-)

Excludes2 inherited from the categories above H35.352

Also inherited, and the opposite of Excludes1: these conditions are not part of H35.352, but a patient can have both, so you may code both.

Written on H35 — Other retinal disorders

diabetic retinal disorders (E08.311-E08.359, E09.311-E09.359, E10.311-E10.359, E11.311-E11.359, E13.311-E13.359)

Risk adjustment

H35.352 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.

Medicare coverage

H35.352 is named in 25 Medicare coverage policies — 25 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52370Billing and Coding: Bevacizumab and biosimilars
A52451Billing and Coding: Ranibizumab, Aflibercept and biosimilars
A52451Billing and Coding: Ranibizumab, Aflibercept and biosimilars
A52451Billing and Coding: Ranibizumab, Aflibercept and biosimilars

Code history

H35.352 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.

Related codes at this level

Codes that share H35.35. If H35.352 is not quite right, the correct code is usually one of these.

Questions about H35.352

Is H35.352 a billable ICD-10-CM code?: Yes. H35.352 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does H35.352 sit in the tabular list?: Diseases of the eye and adnexa (H00-H59), in the block Disorders of choroid and retina (H30-H36).
What cannot be coded together with H35.352?: H35.352 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above H35.352 (H35.35) and apply to it just the same.